AI assistant
Sending…
GeoVax Labs, Inc. — Director's Dealing 2021
Dec 8, 2021
35063_dirs_2021-12-08_a3bdc285-8fff-494a-8aa9-a03d35241ef0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GeoVax Labs, Inc. (GOVX)
CIK: 0000832489
Period of Report: 2021-12-07
Reporting Person: NEWMAN MARK J (Chief Scientific Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-07 | Common Stock (right to buy) | $3.82 | A | 25700 | Acquired | 2031-12-31 | Common Stock (25700) | Direct |
Footnotes
F1: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.
More from GeoVax Labs, Inc.
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 19
Capital/Financing Update
2026
May 18
Earnings Release
2026
May 14
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14